Mitsui Chemicals, Inc. (MITUF)
OTCMKTS · Delayed Price · Currency is USD
12.00
-0.67 (-5.30%)
At close: Dec 31, 2025
Mitsui Chemicals Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 1,689,039 | 1,809,164 | 1,749,743 | 1,879,547 | 1,612,688 | 1,211,725 | |
Revenue Growth (YoY) | -6.89% | 3.40% | -6.91% | 16.55% | 33.09% | -9.50% |
Cost of Revenue | 1,316,621 | 1,420,872 | 1,378,946 | 1,498,054 | 1,233,948 | 917,883 |
Gross Profit | 372,418 | 388,292 | 370,797 | 381,493 | 378,740 | 293,842 |
Selling, General & Admin | 229,179 | 231,789 | 220,769 | 225,718 | 188,282 | 165,680 |
Research & Development | 45,781 | 45,781 | 44,695 | 42,954 | 38,124 | 33,802 |
Other Operating Expenses | 3,697 | -380 | -525 | -1,614 | -690 | -1,830 |
Operating Expenses | 296,225 | 294,758 | 284,901 | 290,765 | 245,977 | 212,715 |
Operating Income | 76,193 | 93,534 | 85,896 | 90,728 | 132,763 | 81,127 |
Interest Expense | -11,389 | -8,515 | -7,866 | -6,078 | -4,083 | -4,811 |
Interest & Investment Income | 7,947 | 7,238 | 6,312 | 5,010 | 2,457 | 2,152 |
Earnings From Equity Investments | 17,513 | 12,429 | 12,302 | 21,693 | 25,819 | 5,989 |
Currency Exchange Gain (Loss) | -3,388 | -3,388 | 6,922 | - | - | - |
Other Non Operating Income (Expenses) | -1,913 | -1,913 | -3,081 | -2,594 | 3,284 | 1,746 |
EBT Excluding Unusual Items | 84,963 | 99,385 | 100,485 | 108,759 | 160,240 | 86,203 |
Impairment of Goodwill | - | - | 939 | - | 7,246 | - |
Gain (Loss) on Sale of Investments | - | - | 2,230 | 23,124 | -4,978 | -3 |
Gain (Loss) on Sale of Assets | -9,223 | -9,223 | -6,167 | -7,136 | -5,050 | -3,392 |
Asset Writedown | -18,515 | -18,515 | -24,156 | -7,455 | -16,183 | -8,050 |
Other Unusual Items | - | - | - | -14 | -1 | -515 |
Pretax Income | 57,225 | 71,647 | 73,331 | 117,278 | 141,274 | 74,243 |
Income Tax Expense | 27,490 | 29,018 | 19,556 | 27,140 | 22,723 | 10,024 |
Earnings From Continuing Operations | 29,735 | 42,629 | 53,775 | 90,138 | 118,551 | 64,219 |
Minority Interest in Earnings | -12,623 | -10,387 | -3,776 | -7,202 | -8,561 | -6,346 |
Net Income | 17,112 | 32,242 | 49,999 | 82,936 | 109,990 | 57,873 |
Net Income to Common | 17,112 | 32,242 | 49,999 | 82,936 | 109,990 | 57,873 |
Net Income Growth | -66.08% | -35.52% | -39.71% | -24.60% | 90.05% | 52.52% |
Shares Outstanding (Basic) | 235 | 378 | 380 | 385 | 389 | 388 |
Shares Outstanding (Diluted) | 235 | 378 | 380 | 385 | 389 | 388 |
Shares Change (YoY) | -38.17% | -0.57% | -1.16% | -1.11% | 0.16% | -0.23% |
EPS (Basic) | 72.93 | 85.28 | 131.49 | 215.59 | 282.73 | 149.00 |
EPS (Diluted) | 72.93 | 85.28 | 131.49 | 215.59 | 282.73 | 149.00 |
EPS Growth | -45.14% | -35.14% | -39.01% | -23.75% | 89.75% | 52.87% |
Free Cash Flow | 66,106 | 79,288 | 17,271 | -31,106 | -14,483 | 99,419 |
Free Cash Flow Per Share | 281.73 | 209.72 | 45.42 | -80.86 | -37.23 | 255.97 |
Dividend Per Share | 37.500 | 75.000 | 70.000 | 60.000 | 57.500 | 50.000 |
Dividend Growth | -48.28% | 7.14% | 16.67% | 4.35% | 15.00% | - |
Gross Margin | 22.05% | 21.46% | 21.19% | 20.30% | 23.48% | 24.25% |
Operating Margin | 4.51% | 5.17% | 4.91% | 4.83% | 8.23% | 6.69% |
Profit Margin | 1.01% | 1.78% | 2.86% | 4.41% | 6.82% | 4.78% |
Free Cash Flow Margin | 3.91% | 4.38% | 0.99% | -1.65% | -0.90% | 8.21% |
EBITDA | 179,371 | 193,302 | 181,145 | 182,808 | 216,985 | 157,748 |
EBITDA Margin | 10.62% | 10.69% | 10.35% | 9.73% | 13.46% | 13.02% |
D&A For EBITDA | 103,178 | 99,768 | 95,249 | 92,080 | 84,222 | 76,621 |
EBIT | 76,193 | 93,534 | 85,896 | 90,728 | 132,763 | 81,127 |
EBIT Margin | 4.51% | 5.17% | 4.91% | 4.83% | 8.23% | 6.69% |
Effective Tax Rate | 48.04% | 40.50% | 26.67% | 23.14% | 16.08% | 13.50% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.